Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy.

Metastatic bone and soft tissue sarcomas often relapse after chemotherapy (CHT) and molecular targeted therapy (mTT), maintaining a severe prognosis. A subset of sarcoma cancer stem cells (sCSC) is hypothesized to resist conventional drugs and sustain disease relapses. We investigated the immunother...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncoimmunology
Asıl Yazarlar: Mesiano, Giulia, Grignani, Giovanni, Fiorino, Erika, Leuci, Valeria, Rotolo, Ramona, D’Ambrosio, Lorenzo, Salfi, Chiara, Gammaitoni, Loretta, Giraudo, Lidia, Pisacane, Alberto, Butera, Sara, Pignochino, Ymera, Basiricó, Marco, Capozzi, Federica, Sapino, Anna, Aglietta, Massimo, Sangiolo, Dario
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Taylor & Francis 2018
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6208452/
https://ncbi.nlm.nih.gov/pubmed/30393581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1465161
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller